المؤلفون: Ye SJ; Health Science Center, Ningbo University, Zhejiang, Ningbo 315211, China., Huang RD; Department of General Surgery, Yuyao People's Hospital, Zhejiang, Ningbo 315400, China., Fei X; Health Science Center, Ningbo University, Zhejiang, Ningbo 315211, China., Tao ZL; Department of Urology, Beilun People's Hospital, Zhejiang, Ningbo 315800, China., Liu WH; Department of Urology, Beilun People's Hospital, Zhejiang, Ningbo 315800, China., Ma Q; Comprehensive Genitourinary Cancer Center, The First Affiliated Hospital of Ningbo University, Zhejiang, Ningbo 315010, China.; Translational Research Laboratory for Urology, The First Affiliated Hospital of Ningbo University, Zhejiang, Ningbo 315010, China.; Yi-Huan Genitourinary Cancer Group, The First Affiliated Hospital of Ningbo University, Zhejiang, Ningbo 315010, China.

المصدر: Postgraduate medical journal [Postgrad Med J] 2024 Sep 22; Vol. 100 (1188), pp. 703-708.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0234135 Publication Model: Print Cited Medium: Internet ISSN: 1469-0756 (Electronic) Linking ISSN: 00325473 NLM ISO Abbreviation: Postgrad Med J Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists*/therapeutic use , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/pathology , Docetaxel*/therapeutic use , Docetaxel*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Male ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/pathology ; Quality of Life ; Antineoplastic Agents, Hormonal/therapeutic use ; Antineoplastic Agents, Hormonal/administration & dosage ; Neoplasm Metastasis

المؤلفون: Conde-Moreno AJ; Department Radiation Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain. Electronic address: conde_ant@gva.es., López-Campos F; Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Hervás A; Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Morillo V; Department of Radiation Oncology, Hospital Provincial de Castellón, Spain., Méndez A; Department of Radiation Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain., Puertas MDM; Department Radiation Oncology, Hospital Miguel Servet, Zaragoza, Spain., Valero-Albarrán J; Department of Radiation Oncology, Hospital HM, Madrid, Spain., Gómez Iturriaga A; Department of Radiation Oncology Hospital Universitario Cruces, Biobizkaia Health Research Institute Basque Country University UPV/EHU, Barakaldo, Spain., Rico M; Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain., Vázquez ML; Department of Radiation Oncology, Complejo Hospitalario Universitario de Vigo, Vigo, Spain., Samper Ots PM; Department of Radiation Oncology, Hospital Universitario Rey Juan Carlos, Móstoles, Spain., Perez-Romasanta LA; Department of Radiation Oncology, Hospital Clínico Universitario de Salamanca, Salamanca, Spain., Pastor J; Department of Radiation Oncology, Hospital ASCIRES, Valencia, Spain., Ibáñez C; Department of Radiation Oncology, Hospital Universitario Gómez Ulla, Madrid, Spain., Ferrer F; Department of Radiation Oncology, Institut Catalá de Oncología, Hospital Universitario de Belvitge, Barcelona, Spain., Zapatero A; Department of Radiation Oncology, Hospital Universitario de la Princesa, Madrid, Spain., García-Blanco AS; Department of Radiation Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Rodríguez A; Department of Radiation Oncology, Hospital Ruber Internacional, Madrid, Spain., Ferrer C; Department of Radiation Oncology, Hospital Provincial de Castellón, Spain.

المصدر: Practical radiation oncology [Pract Radiat Oncol] 2024 Sep-Oct; Vol. 14 (5), pp. e344-e352. Date of Electronic Publication: 2024 Jun 29.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101558279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-8519 (Electronic) Linking ISSN: 18798500 NLM ISO Abbreviation: Pract Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Radiosurgery*/methods , Radiosurgery*/adverse effects , Androgen Antagonists*/therapeutic use , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/therapy, Humans ; Male ; Aged ; Middle Aged ; Aged, 80 and over ; Prospective Studies ; Neoplasm Metastasis ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/radiotherapy

المؤلفون: Lin BB; Department of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, 518000, China.; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, 1088 Xueyuan Blvd, Shenzhen, 518055, China.; Department of Radiotherapy, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, 515041, China., Huang Q; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, 1088 Xueyuan Blvd, Shenzhen, 518055, China., Yan B; Department of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, 518000, China., Liu M; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, 1088 Xueyuan Blvd, Shenzhen, 518055, China., Zhang Z; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, 1088 Xueyuan Blvd, Shenzhen, 518055, China., Lei H; Department of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, 518000, China., Huang R; The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, 515000, China., Dong JT; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, 1088 Xueyuan Blvd, Shenzhen, 518055, China. dongjt@sustech.edu.cn., Pang J; Department of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, 518000, China. pangjun2@mail.sysu.edu.cn.

المصدر: British journal of cancer [Br J Cancer] 2024 Sep; Vol. 131 (5), pp. 870-882. Date of Electronic Publication: 2024 Jul 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/genetics , Prostatic Neoplasms, Castration-Resistant*/pathology , Neoplasm Recurrence, Local*/genetics , Neoplasm Recurrence, Local*/pathology , Endothelial Cells*/metabolism , Endothelial Cells*/pathology, Male ; Humans ; Disease Progression ; Prognosis ; Transcriptome ; Gene Expression Regulation, Neoplastic ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/pathology

المؤلفون: Wang J; Department of Urologic Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230031, China., Ding HK; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230001, China.; Institute of Urology, Anhui Medical University, Hefei 230001, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei 230001, China., Xu HJ; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230001, China.; Institute of Urology, Anhui Medical University, Hefei 230001, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei 230001, China., Hu DK; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230001, China.; Institute of Urology, Anhui Medical University, Hefei 230001, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei 230001, China., Hankey W; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA., Chen L; Department of Geriatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China., Xiao J; Department of Urology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China., Liang CZ; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230001, China.; Institute of Urology, Anhui Medical University, Hefei 230001, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei 230001, China., Zhao B; Department of Geriatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China., Xu LF; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230001, China.; Institute of Urology, Anhui Medical University, Hefei 230001, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei 230001, China.

المصدر: Asian journal of andrology [Asian J Androl] 2024 Sep 01; Vol. 26 (5), pp. 451-463. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Shanghai Materia Medica Country of Publication: China NLM ID: 100942132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7262 (Electronic) Linking ISSN: 1008682X NLM ISO Abbreviation: Asian J Androl Subsets: MEDLINE

مواضيع طبية MeSH: Single-Cell Analysis*/methods , Prostatic Neoplasms*/metabolism , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/genetics, Male ; Humans ; Tumor Microenvironment ; Mitochondria/metabolism ; Prostate/metabolism ; Prostate/pathology ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/genetics ; Epithelial Cells/metabolism

المؤلفون: Fujimoto N; Department of Urology, Local Incorporated Administrative Agency Kurate Hospital, Kurate, Japan; n-fuji@kurate-hp.com.; Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan., Nagata Y; Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan., Shiota M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Minato A; Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan., Tomisaki I; Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan., Harada K; Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan., Eto M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Miyamoto H; Departments of Pathology & Laboratory Medicine and Urology, University of Rochester Medical Center, Rochester, NY, U.S.A.

المصدر: In vivo (Athens, Greece) [In Vivo] 2024 Sep-Oct; Vol. 38 (5), pp. 2328-2334.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE

مواضيع طبية MeSH: Prostate-Specific Antigen*/blood , Androgen Antagonists*/therapeutic use , Androgen Antagonists*/administration & dosage , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology , Prostatic Neoplasms, Castration-Resistant*/mortality, Humans ; Male ; Aged ; Middle Aged ; Treatment Outcome ; Neoplasm Metastasis ; Aged, 80 and over ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/mortality ; Docetaxel/administration & dosage ; Docetaxel/therapeutic use

المؤلفون: Wenzel M; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany., Hoeh B; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany., Wagner N; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany., Koll F; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany., Siech C; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany., Humke C; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany., Steuber T; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Graefen M; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Department of Urology, Koc University Hospital, Istanbul, Turkey., Kluth L; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany., Traumann M; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany., Banek S; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany., Chun FKH; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany., Mandel P; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany.; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

المصدر: Journal of the American Geriatrics Society [J Am Geriatr Soc] 2024 Sep; Vol. 72 (9), pp. 2700-2708. Date of Electronic Publication: 2024 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Science Country of Publication: United States NLM ID: 7503062 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-5415 (Electronic) Linking ISSN: 00028614 NLM ISO Abbreviation: J Am Geriatr Soc Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology , Prostatic Neoplasms, Castration-Resistant*/mortality, Humans ; Male ; Aged ; Aged, 80 and over ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/mortality ; Docetaxel/therapeutic use ; Age Factors ; Neoplasm Metastasis ; Treatment Outcome ; Antineoplastic Agents/therapeutic use ; Retrospective Studies ; Survival Rate ; Androgen Receptor Antagonists/therapeutic use

المؤلفون: Einstein DJ; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA.; Harvard Medical School, Boston, MA., Regan MM; Harvard Medical School, Boston, MA.; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA., Stevens JS; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA., McDermott DF; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA.; Harvard Medical School, Boston, MA., Madan RA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 20; Vol. 42 (24), pp. 2849-2852. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local* , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/mortality , Prostatic Neoplasms*/therapy, Humans ; Male ; Prostate-Specific Antigen/blood ; Disease-Free Survival ; Randomized Controlled Trials as Topic ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/drug therapy

المؤلفون: Suzuki A; Morphological Analysis Laboratory, Kanagawa Cancer Center Research Institute, Yokohama 241-8515, Kanagawa, Japan.; Department of Urology, Kanagawa Cancer Center, Yokohama 241-8515, Kanagawa, Japan., Sato S; Morphological Analysis Laboratory, Kanagawa Cancer Center Research Institute, Yokohama 241-8515, Kanagawa, Japan.; Department of Pathology, Kanagawa Cancer Center, Yokohama 241-8515, Kanagawa, Japan.; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama 241-8515, Kanagawa, Japan., Nakaigawa N; Department of Urology, Kanagawa Cancer Center, Yokohama 241-8515, Kanagawa, Japan., Kishida T; Department of Urology, Kanagawa Cancer Center, Yokohama 241-8515, Kanagawa, Japan., Miyagi Y; Department of Pathology, Kanagawa Cancer Center, Yokohama 241-8515, Kanagawa, Japan.; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama 241-8515, Kanagawa, Japan.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 17; Vol. 25 (16). Date of Electronic Publication: 2024 Aug 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Adiponectin*/blood , Leptin*/blood , Neoplasm Recurrence, Local*/blood , Neoplasm Recurrence, Local*/pathology , Adipose Tissue*/metabolism , Adipose Tissue*/pathology , Prostate-Specific Antigen*/blood , Prostatic Neoplasms*/blood , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/surgery, Humans ; Male ; Aged ; Middle Aged ; Retrospective Studies ; Biomarkers, Tumor/blood ; Prognosis ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/pathology

المؤلفون: Tomić D; Centre for Informatics and Computing, Rudjer Boskovic Institute, 10000, Zagreb, Croatia. drasko@irb.hr., Murgić J; Department of Oncology and Nuclear Medicine, Sisters of Charity Hospital, 10000, Zagreb, Croatia., Fröbe A; Department of Oncology and Nuclear Medicine, Sisters of Charity Hospital, 10000, Zagreb, Croatia., Skala K; Centre for Informatics and Computing, Rudjer Boskovic Institute, 10000, Zagreb, Croatia., Vrljičak A; Department of Oncology and Nuclear Medicine, Sisters of Charity Hospital, 10000, Zagreb, Croatia., Medved Rogina B; Centre for Informatics and Computing, Rudjer Boskovic Institute, 10000, Zagreb, Croatia., Kolarek B; Centre for Informatics and Computing, Rudjer Boskovic Institute, 10000, Zagreb, Croatia., Bojović V; Centre for Informatics and Computing, Rudjer Boskovic Institute, 10000, Zagreb, Croatia.

المصدر: Scientific reports [Sci Rep] 2024 Aug 13; Vol. 14 (1), pp. 18824. Date of Electronic Publication: 2024 Aug 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology, Male ; Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Proof of Concept Study ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/pathology ; Computational Biology/methods

المؤلفون: Venkadakrishnan VB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Presser AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Singh R; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Booker MA; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA., Traphagen NA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Weng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Boston College, Chestnut Hill, MA, USA., Voss NCE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Belmont Hill School, Belmont, MA, USA., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Mizuno K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Puca L; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Idahor O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard University, Cambridge, MA, USA., Ku SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bakht MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Borah AA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Urology, University of California at San Francisco, San Francisco, CA, USA.; Arc Institute, Palo Alto, CA, USA., Herbert ZT; Molecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, MA, USA., Tolstorukov MY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rickman DS; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. himisha_beltran@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. himisha_beltran@dfci.harvard.edu.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA. himisha_beltran@dfci.harvard.edu.

المصدر: Nature communications [Nat Commun] 2024 Aug 08; Vol. 15 (1), pp. 6779. Date of Electronic Publication: 2024 Aug 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Enhancer of Zeste Homolog 2 Protein*/metabolism , Enhancer of Zeste Homolog 2 Protein*/genetics , Gene Expression Regulation, Neoplastic* , Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/metabolism , Prostatic Neoplasms*/pathology, Male ; Humans ; Cell Line, Tumor ; Animals ; Adenocarcinoma/genetics ; Adenocarcinoma/metabolism ; Adenocarcinoma/pathology ; Drug Resistance, Neoplasm/genetics ; Cell Differentiation ; Prostatic Neoplasms, Castration-Resistant/genetics ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Mice ; Cell Lineage